LabCorp (LH) Poised to Outshine Q1 Earnings Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 3:34PM CDT
Laboratory Corp. of America Holdings (LH), or LabCorp, is scheduled to release its first-quarter 2015 results before the opening bell on Apr 27.
HCA: 77.74 (+0.30), MYGN: 33.59 (-0.77), LH: 126.93 (+0.55), MRTX: 27.87 (-0.15)
Should You Buy Laboratory Corp. of America (LH) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 7:54AM CDT
Laboratory Corp. of America (LH) looks poised to beat analyst estimates this earnings season, with a favourable Zacks Rank and an ESP in positive territory.
LH: 126.93 (+0.55)
Will Quest Diagnostics' (DGX) Earnings Surprise in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 11:20AM CDT
Quest Diagnostics Inc. (DGX) is scheduled to report its first-quarter 2015 results before the opening bell on Apr 23.
MYGN: 33.59 (-0.77), DGX: 75.81 (+0.60), LH: 126.93 (+0.55), MRTX: 27.87 (-0.15)
Will Thermo Fisher's (TMO) Q1 Earnings Surprise Investors? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 1:40PM CDT
Thermo Fisher Scientific, Inc. (TMO) is slated to report its first-quarter 2015 earnings numbers before the opening bell on Apr 22.
MYGN: 33.59 (-0.77), TMO: 130.02 (+0.47), LH: 126.93 (+0.55), ILMN: 189.59 (-3.01)
Will Microsoft (MSFT) Disappoint Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 11:50AM CDT
Microsoft Corp. (MSFT) is set to report third-quarter fiscal 2015 results on Apr 23. Last quarter, the company posted a 10.0% positive earnings surprise.
VRX: 210.42 (+1.03), BPOP: 34.25 (-0.50), LH: 126.93 (+0.55), MSFT: 47.87 (+4.53)
Laboratory Corp of America Holdings Shares Up 20.8% Since SmarTrend's Buy Recommendation (LH)
Comtex SmarTrend(R) - Tue Apr 21, 11:39AM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on December 1st, 2014 at $104.34. In approximately 5 months, Laboratory Corp of America Holdings has returned 20.79% as of today's recent price of $126.03.
LH: 126.93 (+0.55)
Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers
PR Newswire - Tue Apr 21, 7:00AM CDT
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Inserm, the French National Institute of Health and Medical Research institution, today launched BRCA Share(TM), a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data. The program's goal is to accelerate research on BRCA gene mutations, particularly variants of uncertain significance, to improve the ability of clinical laboratory diagnostics to predict which individuals are at risk of developing hereditary breast and ovarian cancers.
DGX: 75.81 (+0.60), LH: 126.93 (+0.55)
Will St. Jude Medical's (STJ) Earnings Miss the Mark in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 1:30PM CDT
St. Jude Medical Inc. (STJ) is slated to release its first-quarter 2015 earnings results on Apr 22. Last quarter, the company reported earnings in line with the Zacks Consensus Estimate
VRX: 210.42 (+1.03), STJ: 73.47 (-0.54), LH: 126.93 (+0.55), CGNX: 47.50 (-0.78)
Will Texas Instruments (TXN) Top Earnings Estimates in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 11:50AM CDT
We expect the semiconductor company, Texas Instruments (TXN), or "TI", to beat expectations when it reports first-quarter 2015 results on Apr 22.
VRX: 210.42 (+1.03), BPOP: 34.25 (-0.50), TXN: 54.73 (+0.01), LH: 126.93 (+0.55)
Will Stryker (SYK) Disappoint Earnings Estimates in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 17, 1:00PM CDT
Stryker Corp. (SYK) is slated to release its first-quarter 2015 financials on Apr 21. Last quarter, the company missed the Zacks Consensus Estimate by 0.7%.
VRX: 210.42 (+1.03), LH: 126.93 (+0.55), CGNX: 47.50 (-0.78), SYK: 96.90 (-0.28)
Will Nielsen's (NLSN) Earnings Disappoint Estimates in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 17, 11:30AM CDT
Nielsen Holdings N.V. (NLSN) is set to report first-quarter 2015 results on Apr 22. Last quarter, it posted a 5.3% positive earnings surprise.
NLSN: 45.95 (-0.36), VRX: 210.42 (+1.03), BPOP: 34.25 (-0.50), LH: 126.93 (+0.55)
Do Reverse Splits Ever Work?
Dan Caplinger, The Motley Fool - Motley Fool - Thu Apr 16, 12:00PM CDT
Source: Rafael Matsunaga, Flickr. Stock splits should theoretically have no impact whatsoever on a stock's price. Yet when a stock performs well and announces a stock split, investors often get even more optimistic about its prospects and bid...
CXW: 39.42 (-0.21), ACI: 1.03 (+0.04), LH: 126.93 (+0.55), AIG: 56.99 (+0.24), PCLN: 1,233.09 (+11.99)
Will STERIS' Synergy Health Deal Facilitate Growth Further? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 1:10PM CDT
The Synergy health buyout should boost STERIS' (STE) presence in the international market as it will combine the company's strong presence in North America with Synergy's solid foothold across Europe.
ABC: 115.48 (+0.28), STE: 70.76 (+0.06), LH: 126.93 (+0.55), MMSI: 20.58 (+1.34)
Laboratory Corp of America Holdings Has Returned 19.2% Since SmarTrend Recommendation (LH)
Comtex SmarTrend(R) - Tue Apr 14, 10:21AM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on December 1st, 2014 at $104.34. In approximately 4 months, Laboratory Corp of America Holdings has returned 19.19% as of today's recent price of $124.36.
LH: 126.93 (+0.55)
LabCorp Boosts Specialty Testing with Forensics Partnership - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 3:58PM CDT
Bode Cellmark Forensics, a wholly-owned subsidiary of Laboratory Corporation of America Holdings (LH) recently tied up with the Committee on Missing Persons (CMP).
ABC: 115.48 (+0.28), CAH: 91.38 (-0.12), LH: 126.93 (+0.55), MMSI: 20.58 (+1.34)
Global Drug Screening Market by Products and Services 2015-2019 - Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents
M2 - Mon Apr 13, 6:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v9h2kh/drug_screening) has announced the addition of the "Drug Screening Market by Products and Services, Sample Type - Global Forecast To 2019" report to their offering. The drug and alcohol testing market size, in terms of value, is expected to reach $6.3 billion by 2019 from $4 billion in 2014, at a CAGR of 9.5% The global drug screening market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period. Over the next five years, the growth of the market in the Asian region is likely to be centered on China and India. On the basis of products and services, the drug screening market is segmented into equipment, rapid testing devices, consumables, and laboratory services. The equipment market is further segmented into immunoassay analyzers, chromatography instruments, and breath analyzers. The breath analyzers market is further segmented into fuel cell breath analyzers, semiconductor breath analyzers, and other devices. On the basis of type of sample, the global drug screening market is segmented into urine, breath, saliva, hair, and others (blood and sweat). Based on end users, the market is segmented into workplaces and schools, law enforcement agencies and criminal justice systems, hospitals, pain management centers, drug treatment centers, and drug testing laboratories. Key players in the drug screening market include Quest Diagnostics (U.S.), Laboratory Corporation of America Holdings (U.S.), Alere, Inc., (U.S.), Roche Diagnostics (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Dr?gerwerk AG & Co. KGaA (Germany), Siemens Healthcare (Germany), Express Diagnostics Int'l Inc. (U.S.), Shimadzu (Japan), and MPD, Inc. (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Drug and Alcohol Testing Market, By Products and Services 8 Drug and Alcohol Testing Market, By Sample Type 9 Drug and Alcohol Testing Market, By End Users 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Alere, Inc. - Dr?gerwerk AG & Co. KGAA - Express Diagnostics Int'l, Inc. - Laboratory Corporation of America - MPD, Inc. - Quest Diagnostics - Roche Diagnostics - Shimadzu, Corp. - Siemens Healthcare - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/v9..._screening
DGX: 75.81 (+0.60), LH: 126.93 (+0.55), ALR: 49.97 (-0.04)
Bode Technology Supports Identification of Missing Persons in Cyprus Using DNA
Business Wire - Thu Apr 09, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (LH: NYSE) today announced that its wholly-owned subsidiary Bode Cellmark Forensics (Bode Cellmark), a member of the LabCorp Specialty Testing Group, is cooperating with the Committee on Missing Persons (CMP) in Cyprus in its mission of exhumation, identification, and return of remains of missing persons in Cyprus. The CMP in Cyprus is a bi-communal body established in 1981 by agreement between the Greek Cypriot and Turkish Cypriot communities under the auspices of the United Nations, to determine the fate of persons reported missing due to inter-communal conflict. To date, the CMP has identified more than 570 individuals. Bode Cellmark began issuing DNA kinship match reports to the CMP in November 2014.
LH: 126.93 (+0.55)
Comparing America's Next 3 Medical Laboratories And Research Companies
Joseph Cafariello - at Seeking Alpha - Wed Apr 08, 10:44AM CDT
Q: 69.09 (+1.40), LH: 126.93 (+0.55), PKI: 51.65 (+0.08)
Uptrend Call Working As Laboratory Corp of America Holdings Stock Rises 20.3% (LH)
Comtex SmarTrend(R) - Tue Apr 07, 9:30AM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on December 1st, 2014 at $104.33. In approximately 4 months, Laboratory Corp of America Holdings has returned 20.34% as of today's recent price of $125.56.
LH: 126.93 (+0.55)